Royal Bank of Canada
PASG icon

Royal Bank of Canada’s Passage Bio PASG Stock Holding History

Royal Bank of Canada’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+2
New +$21 ﹤0.01% 7531
2024
Q3 		– Sell
-35
Closed -$1K – 7271
2024
Q2 		$1K Buy
35
+10
+40% +$245 ﹤0.01% 6870
2024
Q1 		$1K Buy
25
+6
+32% +$144 ﹤0.01% 6834
2023
Q4 		$0 Buy
19
+17
+850% +$235 ﹤0.01% 7457
2023
Q3 		$0 Sell
2
-31
-94% -$509 ﹤0.01% 7434
2023
Q2 		$1K Buy
33
+27
+450% +$534 ﹤0.01% 7053
2023
Q1 		$0 Hold
6
– – ﹤0.01% 7364
2022
Q4 		$0 Sell
6
-1
-14% -$25 ﹤0.01% 7582
2022
Q3 		$0 Sell
7
-24
-77% -$946 ﹤0.01% 7737
2022
Q2 		$1K Sell
31
-89
-74% -$4.16K ﹤0.01% 7173
2022
Q1 		$7K Sell
120
-265
-69% -$21.8K ﹤0.01% 7120
2021
Q4 		$48K Buy
385
+135
+54% +$22K ﹤0.01% 6395
2021
Q3 		$50K Buy
250
+67
+37% +$16K ﹤0.01% 6163
2021
Q2 		$49K Buy
183
+52
+40% +$16.1K ﹤0.01% 6062
2021
Q1 		$46K Buy
131
+99
+309% +$42.3K ﹤0.01% 5936
2020
Q4 		$16K Buy
32
+31
+3,100% +$12.4K ﹤0.01% 6165
2020
Q3 		$0 Buy
+1
New +$344 ﹤0.01% 6846

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada's PASG Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Passage Bio (PASG) in Q1 2026: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7531 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in PASG as recently as Q2 2024.

Royal Bank of Canada first reported a position in PASG in Q3 2020 and has held it in 17 quarters since. The position peaked at $50K in Q3 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Royal Bank of Canada held 2 shares of Passage Bio worth $0 as of Q1 2026.
  • Passage Bio was a new Royal Bank of Canada position in Q1 2026.
  • Passage Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7531 holding.
  • Royal Bank of Canada first reported a position in Passage Bio in Q3 2020 and has held it in 17 quarters since.
  • Royal Bank of Canada's Passage Bio position peaked at $50K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.